NEW YORK (Reuters Health), Sep 26 - French anesthesiologists warn that the dyes used for sentinel lymph node mapping can cause anaphylactic reactions that may not develop until an hour after exposure, can be life-threatening, and can last for several hours, requiring continuous infusions of epinephrine to control.
Fourteen cases of anaphylactic reactions to Patent Blue dye occurring between 2004 and 2006 at four centers are reported in the September issue of the Journal of Allergy and Clinical Immunology by Dr. Paul Michel Mertes, of Centre Hospitalier Universitaire de Nancy, and colleagues.
Grade III anaphylactic reactions to Patent Blue occurred in six of the 14 cases. There was an average delay of slightly more than 30 minutes between dye injection and symptom onset, with a minimum of 10 minutes and a maximum of 60 minutes between dye injection and symptom onset in the 14 cases.
Symptom duration was several hours in nine cases (65%), "requiring prolonged continuous epinephrine infusion and transfer to an intensive care unit."
Prick tests were positive in eight cases. In five cases with negative prick tests, positive results were obtained with intradermal testing.
"Our results strongly suggest favoring intradermal tests, using up to a 1:100 dilution for the diagnosis of sensitization to blue dyes in patients with a history of a possible immediate hypersensitivity reaction to dyes," the researchers write.
"We also recommend systematic testing with methylene blue in case of hypersensitivity to Patent Blue dye. Indeed, methylene blue has also been shown to be an effective dye for sentinel lymph node localization, with only a limited number of complications reported."
J Allergy Clin Immunol 2008;122:348-352.
Last Updated: 2008-09-26 12:40:03 -0400 (Reuters Health)
Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
![Overview of the study design. (A) The fully automated deep learning framework was developed to estimate body composition (BC) (defined as subcutaneous adipose tissue [SAT] in liters; visceral adipose tissue [VAT] in liters; skeletal muscle [SM] in liters; SM fat fraction [SMFF] as a percentage; and intramuscular adipose tissue [IMAT] in deciliters) from MRI. The fully automated framework comprised one model (model 1) to quantify different BC measures (SAT, VAT, SM, SMFF, and IMAT) as three-dimensional (3D) measures from whole-body MRI scans. The second model (model 2) was trained to identify standardized anatomic landmarks along the craniocaudal body axis (z coordinate field), which allowed for subdividing the whole-body measures into different subregions typically examined on clinical routine MRI scans (chest, abdomen, and pelvis). (B) BC was quantified from whole-body MRI in over 66,000 individuals from two large population-based cohort studies, the UK Biobank (UKB) (36,317 individuals) and the German National Cohort (NAKO) (30,291 individuals). Bar graphs show age distribution by sex and cohort. BMI = body mass index. (C) After the performance assessment of the fully automated framework, the change in BC measures, distributions, and profiles across age decades were investigated. Age-, sex-, and height-adjusted body composition reference curves were calculated and made publicly available in a web-based z-score calculator (https://circ-ml.github.io).](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/05/body-comp.XgAjTfPj1W.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
